REPL Replimune Group Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: REPL

Price (delayed)

$12.96

Market cap

$1.22B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.15

Enterprise value

$1.15B

?
Relative Growth: Rel. Growth: 7
Relative Strength: Rel. Strength: 95
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4
Highlights
The company's EPS rose by 7% QoQ and by 2.8% YoY
Replimune Group's quick ratio has decreased by 25% YoY but it has increased by 10% from the previous quarter
The net income has contracted by 6% YoY but it has grown by 5% from the previous quarter
The company's equity has shrunk by 69% YoY and by 36% QoQ
Replimune Group's debt has increased by 47% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://replimune.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of REPL

REPL stock price

How has the Replimune Group stock price performed over time
Intraday
-3.79%
1 week
0%
1 month
-12.25%
1 year
199.31%
YTD
33.33%
QTD
17.07%

Financial performance

How have Replimune Group's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$297.74M
Net income
-$297.01M
Gross margin
N/A
Net margin
N/A
The operating income has increased by 7% since the previous quarter
The net income has contracted by 6% YoY but it has grown by 5% from the previous quarter

Price vs fundamentals

How does REPL's price correlate with its fundamentals

Growth

What is Replimune Group's growth rate over time

Valuation

What is Replimune Group stock price valuation
P/E
N/A
P/B
10.3
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 7% QoQ and by 2.8% YoY
REPL's price to book (P/B) is 143% higher than its last 4 quarters average of 4.4
The company's equity has shrunk by 69% YoY and by 36% QoQ

Efficiency

How efficient is Replimune Group business performance
REPL's ROE has shrunk by 130% YoY and by 24% QoQ
Replimune Group's return on invested capital has shrunk by 111% YoY and by 21% QoQ
Replimune Group's return on assets has shrunk by 72% YoY and by 10% QoQ

Dividends

What is REPL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for REPL.

Financial health

How did Replimune Group financials performed over time
The total assets is 72% more than the total liabilities
The total assets is down by 46% YoY and by 24% from the previous quarter
Replimune Group's quick ratio has decreased by 25% YoY but it has increased by 10% from the previous quarter
Replimune Group's debt is 6% more than its equity
The company's equity has shrunk by 69% YoY and by 36% QoQ
The debt to equity has surged by 58% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.